Reminder About Inclusion of Participants in Clinical Research

May 7, 2025

NIH continues to follow all laws (e.g., 42 USC 289a-2) and existing NIH policies that help NIH ensure clinical research includes the appropriate participant demographics to make certain the scientific question under study is addressed in a robust and generalizable manner. Applicants proposing clinical research studies must continue to provide plans including the relevant groups in Section 2 of the PHS Human Subjects and Clinical Trials Information Form.

When developing inclusion plans, applicants should follow the appropriate form instructions found on the How to Apply – Application Guide page.

For more information about NIH inclusion policies, check out the Inclusion Policies for Human Subjects page.

Questions? [email protected]
Categories: Top Stories

Related News

Here’s What We Heard About the Proposed Clinical Trial Specific Application Form, and What’s Next

Earlier this year, we asked the research community to weigh in on a proposed Clinical Trial Specific Application Form that would consolidate clinical trial information currently provided across two application components into a single, semi-structured form with page limits (NOT-OD-26-058). On behalf of the NIH Clinical Trials Application Working Group, I am pleased to share what we heard, and how your feedback will help shape our next steps.

Top Stories

FY25 Inclusion Data for NIH-Supported Clinical Research Now Available by NIH Spending Category

In May, we shared NIH-wide fiscal year (FY) 2025 enrollment data on the sex, race, ethnicity, and age of participants in NIH-supported clinical research, offering a broad view of inclusion across the NIH portfolio. More detailed FY25 enrollment data are now available through the NIH Research, Condition, and Disease Categorization (RCDC) Inclusion Statistics Report.

New Resources
For technical issues E-mail OER Webmaster